Медицински университет - Пловдив

Къде желаете да търсите

Какво желаете да търсите

Търсене в

Подредба

Намерени са 5 резултата. Да не би да имахте предвид mergers?

Разширено търсене

Автор да съдържа M. Berger
Andrews` diseases of the skin
II 14503
Каталог "Книги" | Книга
Andrews` diseases of the skin
Clinical dermatology (2011)
William D. James; Timothy G. Berger; Dirk M. Elson
Evaluation of the combined effects of erucylphospho-N,N,N,-trimethylpropylammonium (ErPC3), Gleevec and Bendamustine on normal and malignantly transformed haemopoietic cells
A 297
Каталог "Статии" | Списание
Evaluation of the combined effects of erucylphospho-N,N,N,-trimethylpropylammonium (ErPC3), Gleevec and Bendamustine on normal and malignantly transformed haemopoietic cells
(2005)
M. Zaharieva; N. Petkov; B. Pilicheva; D. Yosifov; G. Momekov; S. Konstantinov; M. Berger
Erufosine : a membrane targeting antineoplastic agent with signal transduction modulating effects
Каталог "Библиографии" | Списание
Erufosine : a membrane targeting antineoplastic agent with signal transduction modulating effects
M. M. Zacharieva; S. M. Konstantinov; B. Pilicheva; M. Karaivanova; M. R. Berger
Erucylphospho-N,N,N-trimethylpropylammonium (erufosine) is a potential antimyeloma drug devoid of myelotoxicity
Каталог "Библиографии" | Списание
Erucylphospho-N,N,N-trimethylpropylammonium (erufosine) is a potential antimyeloma drug devoid of myelotoxicity
Deyan Y. Yosifov; Plamen Todorov; Maya M. Zaharieva; Kaloyan D. Georgiev; Bissera A. Pilicheva; Spiro M. Konstantinov; Martin R. Berger
Evaluation of the combined effects of erucylphospho-N,N,N,-trimethylpropylammonium (ErPC3), Gleevec and Bendamustine on normal and malignantly transformed haemopoietic cells
A 297
Каталог "Библиографии" | Списание
Evaluation of the combined effects of erucylphospho-N,N,N,-trimethylpropylammonium (ErPC3), Gleevec and Bendamustine on normal and malignantly transformed haemopoietic cells
M. Zaharieva; N. Petkov; B. Pilicheva; D. Yosifov; G. Momekov; S. Konstantinov; M. Berger